A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
NCT ID: NCT03352726
Last Updated: 2019-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
27 participants
INTERVENTIONAL
2017-11-24
2018-06-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects
NCT01489514
High Threshold Peanut Challenge Study
NCT02698033
Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results
NCT06872996
Allergic Disease Onset Prevention Study
NCT05003804
Efficacy of Lyophilized Food Extracts for Skin Prick Tests and Atopy Patch Test at Different Storage Time
NCT03645629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DBV712 Solution for Skin Prick Test
DBV712 In-House Reference Skin Prick Test preparation
DBV712 IHRP
DBV712 Solution for Skin Prick Test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DBV712 IHRP
DBV712 Solution for Skin Prick Test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physician-diagnosed peanut allergy
* Subject currently following a strict peanut-free diet
* Documented history of positive test to peanut-specific IgE (ImmunoCAP system) \>0.7 kU/L
* Positive peanut SPT with a largest wheal diameter ≥ 8 mm
Exclusion Criteria
* Peanut allergen immunotherapy whatever the route, either ongoing or previously started and having lasted more than one month (\>30 days)
* Topical use of steroids within the past 14 days prior to the Screening SPT
* Inability to discontinue short-acting antihistamines
* Atopic dermatitis, eczema or urticaria on the areas to be tested
12 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DBV Technologies
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Children's Hospital Colorado
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BIOPOT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.